These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 24710806

  • 21. "Legal Highs"--An Emerging Epidemic of Novel Psychoactive Substances.
    Zawilska JB.
    Int Rev Neurobiol; 2015; 120():273-300. PubMed ID: 26070762
    [Abstract] [Full Text] [Related]

  • 22. Khat and synthetic cathinones: a review.
    Valente MJ, Guedes de Pinho P, de Lourdes Bastos M, Carvalho F, Carvalho M.
    Arch Toxicol; 2014 Jan; 88(1):15-45. PubMed ID: 24317389
    [Abstract] [Full Text] [Related]

  • 23. Synthetic cathinones ("bath salts").
    Banks ML, Worst TJ, Rusyniak DE, Sprague JE.
    J Emerg Med; 2014 May; 46(5):632-42. PubMed ID: 24565885
    [Abstract] [Full Text] [Related]

  • 24. [Designer drugs and caffeine - characteristics of psychoactive substances and their impact on the organism].
    Wierzejska R.
    Dev Period Med; 2014 May; 18(3):394-9. PubMed ID: 25182406
    [Abstract] [Full Text] [Related]

  • 25. Designer Drugs 2.0.
    Huestis MA, Tyndale RF.
    Clin Pharmacol Ther; 2017 Feb; 101(2):152-157. PubMed ID: 28084644
    [Abstract] [Full Text] [Related]

  • 26. Toxicology and management of novel psychoactive drugs.
    Kersten BP, McLaughlin ME.
    J Pharm Pract; 2015 Feb; 28(1):50-65. PubMed ID: 25261428
    [Abstract] [Full Text] [Related]

  • 27. Synthetic cathinones: "a khat and mouse game".
    Katz DP, Bhattacharya D, Bhattacharya S, Deruiter J, Clark CR, Suppiramaniam V, Dhanasekaran M.
    Toxicol Lett; 2014 Sep 02; 229(2):349-56. PubMed ID: 24973490
    [Abstract] [Full Text] [Related]

  • 28. New Psychoactive Substances (NPS) - the Hydra monster of recreational drugs.
    Helander A, Bäckberg M.
    Clin Toxicol (Phila); 2017 Jan 02; 55(1):1-3. PubMed ID: 27549399
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Spice, bath salts, and the U.S. military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces.
    Loeffler G, Hurst D, Penn A, Yung K.
    Mil Med; 2012 Sep 02; 177(9):1041-8. PubMed ID: 23025133
    [Abstract] [Full Text] [Related]

  • 32. Emerging drugs of abuse: clinical and legal considerations.
    Aoun EG, Christopher PP, Ingraham JW.
    R I Med J (2013); 2014 Jun 02; 97(6):41-5. PubMed ID: 24905374
    [Abstract] [Full Text] [Related]

  • 33. [Synthetic drugs: the new low-cost landscape of drugs].
    Karila L, Petit A, Cottencin O, Coscas S, Reynaud M.
    Rev Prat; 2012 May 02; 62(5):664-6. PubMed ID: 22730798
    [Abstract] [Full Text] [Related]

  • 34. Clinical toxicology of newer recreational drugs.
    Hill SL, Thomas SH.
    Clin Toxicol (Phila); 2011 Oct 02; 49(8):705-19. PubMed ID: 21970769
    [Abstract] [Full Text] [Related]

  • 35. Beta-blocker use for toxicity from "bath salts".
    Richards JR, Laurin EG, Albertson TE.
    J Emerg Med; 2015 Feb 02; 48(2):e45-6. PubMed ID: 25453853
    [No Abstract] [Full Text] [Related]

  • 36. New drugs of abuse.
    Rech MA, Donahey E, Cappiello Dziedzic JM, Oh L, Greenhalgh E.
    Pharmacotherapy; 2015 Feb 02; 35(2):189-97. PubMed ID: 25471045
    [Abstract] [Full Text] [Related]

  • 37. Substituted cathinone products: a new trend in "bath salts" and other designer stimulant drug use.
    Gunderson EW, Kirkpatrick MG, Willing LM, Holstege CP.
    J Addict Med; 2013 Feb 02; 7(3):153-62. PubMed ID: 23732954
    [Abstract] [Full Text] [Related]

  • 38. GHB and synthetic cathinones: clinical effects and potential consequences.
    Karila L, Reynaud M.
    Drug Test Anal; 2011 Sep 02; 3(9):552-9. PubMed ID: 21960540
    [Abstract] [Full Text] [Related]

  • 39. Patterns of Use, Acute Subjective Experiences, and Motivations for Using Synthetic Cathinones ("Bath Salts") in Recreational Users.
    Ashrafioun L, Bonadio FA, Baik KD, Bradbury SL, Carhart VL, Cross NA, Davis AK, Feuille M, Harper AR, Lackey JH, Lang B, Lauritsen KJ, Leith J, Osborn LA, Rosenberg H, Stock J, Zaturenskaya M.
    J Psychoactive Drugs; 2016 Sep 02; 48(5):336-343. PubMed ID: 27681583
    [Abstract] [Full Text] [Related]

  • 40. Synthetic cannabinoid and cathinone use among US soldiers.
    Berry-Cabán CS, Kleinschmidt PE, Rao DS, Jenkins J.
    US Army Med Dep J; 2012 Sep 02; ():19-24. PubMed ID: 23007932
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.